Putnam Investments’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-140,218
| Closed | -$2.09M | – | 952 |
|
2019
Q2 | $2.09M | Sell |
140,218
-258,057
| -65% | -$3.84M | ﹤0.01% | 719 |
|
2019
Q1 | $9.89M | Sell |
398,275
-587,228
| -60% | -$14.6M | 0.02% | 355 |
|
2018
Q4 | $17.7M | Sell |
985,503
-91,680
| -9% | -$1.65M | 0.05% | 239 |
|
2018
Q3 | $31.6M | Buy |
1,077,183
+472,529
| +78% | +$13.9M | 0.07% | 207 |
|
2018
Q2 | $27.5M | Sell |
604,654
-380,319
| -39% | -$17.3M | 0.06% | 218 |
|
2018
Q1 | $52M | Buy |
984,973
+190
| +0% | +$10K | 0.12% | 171 |
|
2017
Q4 | $67M | Buy |
984,783
+157,628
| +19% | +$10.7M | 0.15% | 150 |
|
2017
Q3 | $68.2M | Buy |
827,155
+247,912
| +43% | +$20.4M | 0.16% | 147 |
|
2017
Q2 | $54.2M | Buy |
579,243
+459,901
| +385% | +$43.1M | 0.13% | 155 |
|
2017
Q1 | $7.6M | Buy |
119,342
+76,157
| +176% | +$4.85M | 0.02% | 457 |
|
2016
Q4 | $1.92M | Sell |
43,185
-2,513
| -5% | -$112K | ﹤0.01% | 850 |
|
2016
Q3 | $1.65M | Sell |
45,698
-6,769
| -13% | -$244K | ﹤0.01% | 899 |
|
2016
Q2 | $720K | Buy |
52,467
+25,244
| +93% | +$346K | ﹤0.01% | 1150 |
|
2016
Q1 | $523K | Sell |
27,223
-4,373
| -14% | -$84K | ﹤0.01% | 1238 |
|
2015
Q4 | $1.11M | Buy |
+31,596
| New | +$1.11M | ﹤0.01% | 1137 |
|
2013
Q3 | – | Sell |
-70,000
| Closed | -$4.69M | – | 1506 |
|
2013
Q2 | $4.69M | Buy |
+70,000
| New | +$4.69M | 0.01% | 711 |
|